SAB Biotherapeutics reports Q1 2026 results, enrollment progress
Go back to SAB Biotherapeutics reports Q1 2026 results, enrollment progress| (NASDAQ: SABS) | Delayed: 3.70 -0.01 (0.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.71 | 52 Week High | $ | |||
| Open | $3.65 | 52 Week Low | $ | |||
| Day High | $3.75 | P/E | N/A | |||
| Day Low | $3.65 | EPS | $ | |||
| Volume | 202,283 | |||||
| (NASDAQ: SABSW) | Delayed: 0.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.02 | 52 Week High | $ | |||
| Open | $0.02 | 52 Week Low | $ | |||
| Day High | $0.03 | P/E | N/A | |||
| Day Low | $0.02 | EPS | $ | |||
| Volume | 1,407 | |||||

